Multidisciplinary molecular tumour board: a tool to improve clinical practice and selection accrual for clinical trials in patients with cancer-Reference-Cited by-同舟云学术

Multidisciplinary molecular tumour board: a tool to improve clinical practice and selection accrual for clinical trials in patients with cancer

Published:2018 Issue:5 Volume:3 Page:e000398
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Rolfo Christian^ORCID,Manca Paolo^ORCID,Salgado Roberto,Van Dam Peter^ORCID,Dendooven Amelie,Ferri Gandia Jose,Rutten Annemie,Lybaert Willem,Vermeij Joanna,Gevaert Thomas,Weyn Christine,Lefebure Anneke,Metsu Sofie,Van Laere Steven,Peeters Marc,Pauwels Patrick,Machado Coelho Andreia

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference25 articles.

1. Whole-exome sequencing and clinical interpretation of formalin-fixed;Van Allen;paraffin-embedded tumor samples to guide precision cancer medicine,2014

2. Genomic alterations in circulating tumor DNA from Diverse Cancer Patients Identified by Next-Generation Sequencing;Schwaederle;Cancer Res,2017

3. Effect of expanded genomic testing in lung adenocarcinoma (LUCA) on survival benefit: The Lung Cancer Mutation Consortium II (LCMC II) experience;Aisner;J Clin Oncol,2016

4. Genomic profiling of advanced non-small cell lung cancer in community settings: gaps and opportunities;Gutierrez;Clin Lung Cancer,2017

5. Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: cross-over analysis from the SHIVA trial;Belin;Ann Oncol,2017

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of molecular biology in the management of pancreatic cancer;World Journal of Gastrointestinal Oncology;2024-07-15

2. Unlocking the potential of Molecular Tumor Boards: from cutting-edge data interpretation to innovative clinical pathways;Critical Reviews in Oncology/Hematology;2024-07

3. A Concise Overview of Circulating Tumor DNA Detection for Solid Tumors;Advances in Molecular Pathology;2024-07

4. Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohort;Journal of Translational Medicine;2024-05-15

5. Concept and feasibility of the Augsburg Longitudinal Plasma Study (ALPS) – a prospective trial for comprehensive liquid biopsy-based longitudinal monitoring of solid cancer patients;Journal of Laboratory Medicine;2024-04-19